CKD273, a new proteomics classifier assessing CKD and its prognosis.

Argilés, Ángel et al.·PloS one·2013·
RPEP-021212013RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
CKD273, a new proteomics classifier assessing CKD and its prognosis.
Published In:
PloS one, 8(5), e62837 (2013)
Database ID:
RPEP-02121

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-02121·https://rethinkpeptides.com/research/RPEP-02121

APA

Argilés, Ángel; Siwy, Justyna; Duranton, Flore; Gayrard, Nathalie; Dakna, Mohammed; Lundin, Ulrika; Osaba, Lourdes; Delles, Christian; Mourad, Georges; Weinberger, Klaus M; Mischak, Harald. (2013). CKD273, a new proteomics classifier assessing CKD and its prognosis.. PloS one, 8(5), e62837. https://doi.org/10.1371/journal.pone.0062837

MLA

Argilés, Ángel, et al. "CKD273, a new proteomics classifier assessing CKD and its prognosis.." PloS one, 2013. https://doi.org/10.1371/journal.pone.0062837

RethinkPeptides

RethinkPeptides Research Database. "CKD273, a new proteomics classifier assessing CKD and its pr..." RPEP-02121. Retrieved from https://rethinkpeptides.com/research/argiles-2013-ckd273-a-new-proteomics

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.